SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

SOPHiA GENETICS SA (NASDAQ:SOPH)

CH · Delayed Price · Currency is USD
7.32+0.17 (+2.38%)
 
Market Cap614.11M+63.4%
Revenue (ttm)86.17M+23.6%
Net Income-80.88M-10.2%
EPS-1.15-4.5%
Shares Out83.90M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume244,618
Open7.15
Previous Close7.15
Day's Range6.86 - 7.33
52-Week Range3.75 - 8.98
Beta0.95
AnalystsBuy
Price Target11.50(+57.10%)
Earnings DateNov 3, 2026
+2.38% (1D)
No price history available.
Insider Score
––Not scored
SOPH Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

About SOPH

SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.

Address
La Piece 12, Rolle, VD, 1180, CH
Market Cap
614 million
Employees
415
Industrial Classification
Medical - Healthcare Information Services

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$1.61M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
+2.38%
5 Days
-9.63%
1 Month
-12.44%
6 Months
+50.62%
1 Year
+63.39%

$SOPH stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in SOPH holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by SOPH's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

SOPH Estimated quarterly lobbying spending

Source: U.S. Senate LDA

SOPH Revenue by Segment or Geography

SOPH's latest filing doesn't break out revenue by segment.

Source: SEC EDGAR (10-Q/10-K)

U.S. Patents

New SOPH patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to SOPH from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in SOPH

ETFEst. Holding Size
GWXState Street SPDR S&P International Small Cap ETF$338.64K
MEDIHarbor Health Care ETF (MEDI)$179.09K
AIMSAcuitas Small Cap Active ETF$144.15K
GNMXCorgi ETF Trust I - Corgi Genomics & Precision Medicine ETF$7.06K

Estimated from each fund’s disclosed top holdings × AUM

SOPH Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for SOPH is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from SOPH’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
0
Sells
30
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.